Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXR | Daxor Common Stock | Award | $0 | +2K | +25.81% | $0.00 | 9.75K | Oct 31, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXR | Stock Options (right to buy) | Award | $0 | +5K | $0.00 | 5K | Oct 31, 2023 | COMMON STOCK | 5K | $7.99 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Shares granted vest in three (3) equal installments. 666 vest on October 31, 2023; 666 will vest on October 31, 2024; and 668 will vest on October 31, 2025 |
F2 | Stock options granted on October 31, 2023 are contingent on certain regulatory approvals. |
F3 | The stock options will vest in three installments. 1,666 vest on October 31, 2023; 1,666 will vest October 31, 2024; and 1,668 will vest on October 31, 2026. |